A retrospective examination of transurethral resection of a bladder tumor with continuous antithrombotic therapy

Tetsuya Nakada, Kosuke Takamura, Shingo Nishimura, Makoto Kobuke

Research output: Contribution to journalArticle

Abstract

An increasing elderly population has resulted in an increase in the number of patients receiving antithrombotic therapy who need to undergo urological surgery, and thus we are experiencing difficulty treating such patients in daily medical practice more frequently than in the past. In our department, transurethral resection of a bladder tumor (TURBT) has been performed in 333 patients during a period of 3 years and 9 months since April 2011. Among these patients, 110 (33%) had received some antithrombotic therapy prior to surgery. We retrospectively examined the cases of TURBT with continuous preoperative antithrombotic therapy. The preoperative antithrombotic therapy included anticoagulant therapy only in 10 patients (3%), antiplatelet therapy only in 85 patients (26%), and a combination of anticoagulant and antiplatelet therapy in 15 patients (5%). Compared to the 223 patients without antithrombotic therapy (control group), the 58 patients with continuous perioperative antithrombotic therapy showed no increase in the incidence of postoperative hemorrhage and experienced no perioperative cerebral-cardiovascular events. Postoperative hemorrhage developed in only 1 patient, with idiopathic thrombocytopenic purpura, and a transfusion was given. Thromboembolism, one of the perioperative complications, can be serious and may carry a poor prognosis in many cases. In cases of TURBT, on the other hand, appropriate management can decrease the risk for hemorrhagic complications. Even if such complications do develop, hemorrhagic complications are extremely unlikely to have a life-threatening effect. Thus, the results of our examination suggest that continuous antithrombotic therapy is very effective in cases of TURBT.

Original languageEnglish
Pages (from-to)289-296
Number of pages8
JournalNishinihon Journal of Urology
Volume77
Issue number8
Publication statusPublished - Aug 1 2015
Externally publishedYes

Fingerprint

Urinary Bladder Neoplasms
Therapeutics
Postoperative Hemorrhage
Anticoagulants
Idiopathic Thrombocytopenic Purpura
Thromboembolism
Control Groups
Incidence

Keywords

  • Antithrombotic therapy
  • Bladder tumor
  • TURBT

ASJC Scopus subject areas

  • Urology

Cite this

A retrospective examination of transurethral resection of a bladder tumor with continuous antithrombotic therapy. / Nakada, Tetsuya; Takamura, Kosuke; Nishimura, Shingo; Kobuke, Makoto.

In: Nishinihon Journal of Urology, Vol. 77, No. 8, 01.08.2015, p. 289-296.

Research output: Contribution to journalArticle

@article{45bdd4c043f448ad8bb6d319b4aa2920,
title = "A retrospective examination of transurethral resection of a bladder tumor with continuous antithrombotic therapy",
abstract = "An increasing elderly population has resulted in an increase in the number of patients receiving antithrombotic therapy who need to undergo urological surgery, and thus we are experiencing difficulty treating such patients in daily medical practice more frequently than in the past. In our department, transurethral resection of a bladder tumor (TURBT) has been performed in 333 patients during a period of 3 years and 9 months since April 2011. Among these patients, 110 (33{\%}) had received some antithrombotic therapy prior to surgery. We retrospectively examined the cases of TURBT with continuous preoperative antithrombotic therapy. The preoperative antithrombotic therapy included anticoagulant therapy only in 10 patients (3{\%}), antiplatelet therapy only in 85 patients (26{\%}), and a combination of anticoagulant and antiplatelet therapy in 15 patients (5{\%}). Compared to the 223 patients without antithrombotic therapy (control group), the 58 patients with continuous perioperative antithrombotic therapy showed no increase in the incidence of postoperative hemorrhage and experienced no perioperative cerebral-cardiovascular events. Postoperative hemorrhage developed in only 1 patient, with idiopathic thrombocytopenic purpura, and a transfusion was given. Thromboembolism, one of the perioperative complications, can be serious and may carry a poor prognosis in many cases. In cases of TURBT, on the other hand, appropriate management can decrease the risk for hemorrhagic complications. Even if such complications do develop, hemorrhagic complications are extremely unlikely to have a life-threatening effect. Thus, the results of our examination suggest that continuous antithrombotic therapy is very effective in cases of TURBT.",
keywords = "Antithrombotic therapy, Bladder tumor, TURBT",
author = "Tetsuya Nakada and Kosuke Takamura and Shingo Nishimura and Makoto Kobuke",
year = "2015",
month = "8",
day = "1",
language = "English",
volume = "77",
pages = "289--296",
journal = "Nishinihon Journal of Urology",
issn = "0029-0726",
publisher = "Kyushu University, Faculty of Science",
number = "8",

}

TY - JOUR

T1 - A retrospective examination of transurethral resection of a bladder tumor with continuous antithrombotic therapy

AU - Nakada, Tetsuya

AU - Takamura, Kosuke

AU - Nishimura, Shingo

AU - Kobuke, Makoto

PY - 2015/8/1

Y1 - 2015/8/1

N2 - An increasing elderly population has resulted in an increase in the number of patients receiving antithrombotic therapy who need to undergo urological surgery, and thus we are experiencing difficulty treating such patients in daily medical practice more frequently than in the past. In our department, transurethral resection of a bladder tumor (TURBT) has been performed in 333 patients during a period of 3 years and 9 months since April 2011. Among these patients, 110 (33%) had received some antithrombotic therapy prior to surgery. We retrospectively examined the cases of TURBT with continuous preoperative antithrombotic therapy. The preoperative antithrombotic therapy included anticoagulant therapy only in 10 patients (3%), antiplatelet therapy only in 85 patients (26%), and a combination of anticoagulant and antiplatelet therapy in 15 patients (5%). Compared to the 223 patients without antithrombotic therapy (control group), the 58 patients with continuous perioperative antithrombotic therapy showed no increase in the incidence of postoperative hemorrhage and experienced no perioperative cerebral-cardiovascular events. Postoperative hemorrhage developed in only 1 patient, with idiopathic thrombocytopenic purpura, and a transfusion was given. Thromboembolism, one of the perioperative complications, can be serious and may carry a poor prognosis in many cases. In cases of TURBT, on the other hand, appropriate management can decrease the risk for hemorrhagic complications. Even if such complications do develop, hemorrhagic complications are extremely unlikely to have a life-threatening effect. Thus, the results of our examination suggest that continuous antithrombotic therapy is very effective in cases of TURBT.

AB - An increasing elderly population has resulted in an increase in the number of patients receiving antithrombotic therapy who need to undergo urological surgery, and thus we are experiencing difficulty treating such patients in daily medical practice more frequently than in the past. In our department, transurethral resection of a bladder tumor (TURBT) has been performed in 333 patients during a period of 3 years and 9 months since April 2011. Among these patients, 110 (33%) had received some antithrombotic therapy prior to surgery. We retrospectively examined the cases of TURBT with continuous preoperative antithrombotic therapy. The preoperative antithrombotic therapy included anticoagulant therapy only in 10 patients (3%), antiplatelet therapy only in 85 patients (26%), and a combination of anticoagulant and antiplatelet therapy in 15 patients (5%). Compared to the 223 patients without antithrombotic therapy (control group), the 58 patients with continuous perioperative antithrombotic therapy showed no increase in the incidence of postoperative hemorrhage and experienced no perioperative cerebral-cardiovascular events. Postoperative hemorrhage developed in only 1 patient, with idiopathic thrombocytopenic purpura, and a transfusion was given. Thromboembolism, one of the perioperative complications, can be serious and may carry a poor prognosis in many cases. In cases of TURBT, on the other hand, appropriate management can decrease the risk for hemorrhagic complications. Even if such complications do develop, hemorrhagic complications are extremely unlikely to have a life-threatening effect. Thus, the results of our examination suggest that continuous antithrombotic therapy is very effective in cases of TURBT.

KW - Antithrombotic therapy

KW - Bladder tumor

KW - TURBT

UR - http://www.scopus.com/inward/record.url?scp=84941116381&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941116381&partnerID=8YFLogxK

M3 - Article

VL - 77

SP - 289

EP - 296

JO - Nishinihon Journal of Urology

JF - Nishinihon Journal of Urology

SN - 0029-0726

IS - 8

ER -